Form 4: Sally Beauty CEO Awarded Performance Stock Units

Sentiment:

Insider Transaction Report


Sally Beauty Holdings CEO Denise Paulonis received multiple grants of performance-based restricted stock units tied to company performance metrics and future vesting schedules.

Summary

  • Denise Paulonis, President & CEO and Director of Sally Beauty Holdings, Inc. (SBH), reported several grants of Restricted Stock Units (RSUs).
  • A total of 76,832 performance stock units (PSUs) were earned based on relative total shareholder return (rTSR) goals over a three-year period ending September 30, 2025, with payout on November 15, 2025.
  • An additional 32,088 PSUs were earned based on adjusted operating income margin (AOIM) goals for the third one-year performance period (October 1, 2024, to September 30, 2025) of a grant made on November 2, 2022, with payout on November 15, 2025.
  • Another 57,480 PSUs were earned based on AOIM goals for the second one-year performance period (October 1, 2024, to September 30, 2025) of a grant made on November 1, 2023, with payout on November 15, 2026.
  • A further 40,605 PSUs were earned based on AOIM goals for the first one-year performance period (October 1, 2024, to September 30, 2025) of a grant made on November 6, 2024, with payout on November 15, 2027.
  • A grant of 242,550 restricted stock units will vest in three equal installments on November 15, 2026, November 15, 2027, and November 15, 2028.
  • All restricted stock units convert into common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The filing reports the grant of performance-based equity awards to the CEO, indicating continued alignment of executive incentives with shareholder value and company performance goals. This is generally viewed positively as it ties executive compensation to company performance.

Positives

  • The CEO's receipt of performance-based equity awards aligns management incentives with shareholder interests.
  • The grants indicate the achievement of performance goals related to relative total shareholder return (rTSR) and adjusted operating income margin (AOIM) for various periods.

Future Outlook

The filing details future vesting and payout dates for various equity awards, extending through November 15, 2028, contingent on continued service and the achievement of previously certified performance goals related to relative total shareholder return and adjusted operating income margin.

Industry Context

This Form 4 filing is a standard disclosure of executive equity compensation, reflecting common practices in publicly traded companies to incentivize leadership through performance-based awards. It does not provide direct insights into broader industry trends but confirms the company's ongoing use of long-term incentive plans.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Committee CertificationThe Compensation and Talent Committee of the Board of Directors certified the level of achievement of relative total shareholder return (rTSR) and adjusted operating income margin (AOIM) goals, leading to the earning of performance stock units.N/AEnsures executive compensation is tied to pre-defined performance metrics and board oversight.
Power of Attorney GrantDenise Paulonis granted a Power of Attorney to Scott Sherman, Marlo Cormier, Rebecca L. Morley, and Dennis Ko to execute and file Forms 3, 4, and 5 on her behalf.2025-11-05Standardizes and streamlines the process for filing Section 16 reports for the reporting person, ensuring timely compliance with SEC regulations.

Stakeholder Impact

  • Shareholders: Positive impact due to the alignment of executive compensation with company performance metrics, potentially driving long-term value creation.
  • Employees: No direct impact mentioned, but successful company performance driven by executive incentives could indirectly benefit employees.

Next Steps

  • Payout of 76,832 PSUs and 32,088 PSUs on November 15, 2025.
  • Payout of 57,480 PSUs and first vesting installment of 242,550 RSUs on November 15, 2026.
  • Payout of 40,605 PSUs and second vesting installment of 242,550 RSUs on November 15, 2027.
  • Third and final vesting installment of 242,550 RSUs on November 15, 2028.

Key Dates

DateDescription
2022-11-02Grant date for PSUs tied to rTSR and the first AOIM-based PSU grant.
2023-11-01Grant date for the second AOIM-based PSU grant.
2024-10-01Start date for the third one-year performance period for the first AOIM-based PSU grant, and the second one-year performance period for the second AOIM-based PSU grant, and the first one-year performance period for the third AOIM-based PSU grant.
2024-11-06Grant date for the third AOIM-based PSU grant.
2025-09-30End date for the three-year performance period for rTSR-based PSUs and the one-year performance periods for AOIM-based PSUs.
2025-11-05Date of earliest transaction reported; also the grant date for 242,550 restricted stock units.
2025-11-05Date Denise Paulonis executed the Power of Attorney.
2025-11-07Signature date of the reporting person's attorney-in-fact on the Form 4.
2025-11-15Payout date for 76,832 rTSR-based PSUs and 32,088 AOIM-based PSUs.
2026-01-13Expiration date of the Notary Public's commission for the Power of Attorney.
2026-11-15Payout date for 57,480 AOIM-based PSUs and first vesting installment for 242,550 restricted stock units.
2027-11-15Payout date for 40,605 AOIM-based PSUs and second vesting installment for 242,550 restricted stock units.
2028-11-15Third and final vesting installment for 242,550 restricted stock units.

Keywords

Sally Beauty Holdings, SBH, Denise Paulonis, Restricted Stock Units, Performance Stock Units, Equity Compensation, Insider Transaction, Executive Compensation, Corporate Governance, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.